PCT-guided antibiotic use in critically ill adults
Part of Infections clinical trials.
This trial tests whether using a blood test called 'PCT' can help doctors decide when to start or stop antibiotics in critically ill adult patients in the EICU. The goal is to reduce unnecessary antibiotic use while still effectively treating bacterial infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a suspected or confirmed bacterial infection that may need antibiotics.
- You have been in the Emergency Intensive Care Unit (EICU) for more than 3 days.
- Your blood PCT level (a marker of infection) has been 0.5 ng/mL or higher at some point during your hospital stay.
- You are not pregnant, and you do not have a very low white blood cell count (from chemotherapy or a bone marrow transplant) that would make antibiotics less effective.
- You do not have a long-term infection (like endocarditis, bone infection, or tuberculosis) that requires a specific, prolonged antibiotic treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of using a blood test called procalcitonin to decide when to start antibiotics in critically ill patients with a new infection. The goal is to reduce unnecessary antibiotic use while still effectively treating infections.
This trial tests a computer tool to help doctors choose the right antibiotic for sepsis early on. It may help improve treatment by providing personalized recommendations based on your condition.
This trial tests whether giving a certain type of antibiotic (beta-lactam) continuously or intermittently works better for patients in the intensive care unit with pneumonia or a urinary tract infection and signs of sepsis. Sepsis is a serious response to an infection, so better antibiotic delivery could improve outcomes.
This trial tests a type of antibiotic called aminoglycosides to treat early sepsis (a serious infection). It is for adults in the hospital who are sick enough to need strong antibiotics but not in the worst stage of the illness.
This trial compares two common antibiotics, meropenem and piperacillin/tazobactam, to see which works better for adults with sepsis who are critically ill. It aims to help doctors choose the best treatment for serious infections.
This study compares two antibiotics—piperacillin-tazobactam or temocillin—to treat severe ICU infections caused by certain hard-to-treat gut bacteria (ESBL). It may help patients avoid the use of carbapenem antibiotics like meropenem when the bacteria are susceptible.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.